CHMP fandt, at selv om der ikke er grund til at formode, at individualiseret dosistitrering ikke vil virke for flertallet af patienter, er højeste dosis ikke undersøgt, og CHMP anså patientantallet (n=8) for at være for lille til at drage troværdige konklusioner på grund af det begrænsede antal observationer og den manglende statistiske analyse af de tilgængelige data.
The CHMP considered that while there are no reasons to suspect that individualised dose titration would not work for the majority of the patients, the CHMP noted that the highest dose was not studied and considered the study size (n=8) to be too small to draw any reliable conclusions due to the limited number of observations and the absence of statistical analysis of the available data.